Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2019

Dec 31, 2019

29777_dirs_2019-12-30_f1339f5e-76eb-485d-8c7a-7dbf061b3e89.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2019-12-12

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-12-12 Common shares without par value G 1014 Disposed 3173151 Direct
2019-12-13 Common shares without par value G 12382 Disposed 3160769 Direct
2019-12-23 Common shares without par value G 298 Disposed 3160471 Direct
2019-12-12 Common shares without par value G 507 Acquired 507 Indirect
2019-12-12 Common shares without par value G 507 Disposed 0 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 33966 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 29, 2019.

F2: The reporting person disclaims beneficial ownership of all securities held by his wife.